Page 154 - CW E-Magazine (26-3-2024)
P. 154

News from Abroad


       LEVERAGING BIOTECH SKILLS
       Evonik sets up new research network dedicated

       to skin sciences


          German speciality chemicals group,
       Evonik, has established a network of
       experts and laboratories  to meet  the
       demand for smartly designed, well-sub-
       stantiated active  ingredients and  cos-
       metic  solutions.  The ‘Evonik Skin
       Institute’  will leverage the company’s
       biotechnology platform within its life
       sciences division, Nutrition & Care.

          “The Evonik Skin Institute is made
       up of a global network of life science
       experts and laboratories that provide  a series of  recent partnerships and   and personal care ingredients are used
       customers with stronger support for  acquisitions.                 to precisely describe their scientifically
       claim-substantiated cosmetics with bio-                            proven  benefits  and  provide  a  perfor-
       logical mechanisms, biomarkers, and   “We believe that life sciences are  mance commitment  that helps to pro-
       preclinical  or  clinical capabilities,”  completely  redefining  innovation  in  mote each product. Examples of claims
       a company press  note informed.  The  cosmetics,”  said Mr.  Yann d’Hervé,  include: “soothes the skin” or “reduces
       experts would be skilled in cell bio-  head of the Care Solutions business  wrinkles”.
       logy, 3D tissue engineering, epigenetics,   line.
       microbiome  sciences, and clinical                                    The Evonik Skin Institute will bring
       evaluation.  The new institute supports    “We look forward to working with  together the knowledge and experience
       Evonik’s  Active Ingredients and   an integrated network of start-ups, aca-  that Evonik has built up over 30 years
       Cosmetic Solutions businesses with its  demic institution and key opinion lead-  of designing and marketing ceramides.
       teams based in Singapore, India, Spain  ers to provide more opportunities and  This expertise  has been further en-
       and Germany.                      support for highly customer-centric,  hanced through a series of acquisitions,
                                         business-for-business collaboration,”  including the  Argentinian biotechno-
          The new institute  will also enable  added Ms. Jennifer Bourland, head of  logy company Novachem, which specia-
       more science-driven, co-creation pro-  the Evonik Skin Institute. Ingredients  lises in natural  and sustainable  active
       jects and it will play an important role in   and products must interact  positively  ingredients for skin and hair care appli-
       expanding the company’s  portfolio  and intelligently with the skin and cut-  cations, and Alkion Biopharma, which
       of biosolutions, building on a 30-year   ting-edge science is revealing the role  specialises in plant biotechnology for
       legacy in active ingredients, over 90 years’   of the microbiome and living world in  the development of  cosmetic active
       experience in cosmetic ingredients, and   this interaction. Claims  for cosmetic  ingredients.

       Elkem exits battery materials firm, Vianode


          Norwegian silicones specialist,   Altor Fund Manager. The financial  a focus on Elkem’s core business.
       Elkem, said it has decided to exit  details  of  the  transaction  were not  Going forward,  Vianode will con-
       its financial investment in the ad-  disclosed.                    tinue to be backed by Hydro and
       vanced battery materials company,                                  Altor Fund V, Elkem said. In 2022,
       Vianode, which it jointly owns      This is in line with the previously   Hydro and  Altor Equity Partners
       with global aluminium and renew-  announced comprehensive pro-     had each acquired 30% ownership
       able energy company, Hydro, and  gramme for earnings improvements  in  Vianode,  while  Elkem  retained
       Altor Fund  V, a fund managed by  and capex reductions in Elkem, and  the remaining 40% ownership.


       154                                                                    Chemical Weekly  March 26, 2024


                                      Contents    Index to Advertisers    Index to Products Advertised
   149   150   151   152   153   154   155   156   157   158   159